Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. (Q50192754)
Jump to navigation
Jump to search
scientific article published on 19 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. |
scientific article published on 19 January 2017 |
Statements
1 reference
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. (English)
1 reference
Sophia Gayle
1 reference
Sean Landrette
1 reference
Neil Beeharry
1 reference
Chris Conrad
1 reference
Marylens Hernandez
1 reference
Paul Beckett
1 reference
Shawn M Ferguson
1 reference
Talya Mandelkern
1 reference
Meiling Zheng
1 reference
Tian Xu
1 reference
Jonathan Rothberg
1 reference
Henri Lichenstein
1 reference
19 January 2017
1 reference
1 reference
129
1 reference
13
1 reference
1768-1778
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference